Lenalidomide in non-deletion 5q lower-risk myelodysplastic syndromes: a glass quarter full or three quarters empty??

摘要

Myelodysplastic syndromes (MDS) are a group of clonal bone marrow failure disorders characterized by disorganized, unproductive as well as malignant hematopoiesis. MDS typically manifest with varying degree of cytopenias, mostly anemia, requiring regular red blood cell transfusions in many patients.